Literature DB >> 10805164

Evaluating the mechanism of action of antiproliferative antisense drugs.

S T Crooke1.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10805164     DOI： 10.1089/oli.1.2000.10.123

Source DB:  PubMed          Journal:  Antisense Nucleic Acid Drug Dev        ISSN： 1087-2906


× No keyword cloud information.
  7 in total

Review 1.  Personalized cancer approach: using RNA interference technology.

Authors:  John Nemunaitis; Donald D Rao; Shi-He Liu; F Charles Brunicardi
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

Review 2.  Non-coding RNAs as drug targets.

Authors:  Masayuki Matsui; David R Corey
Journal:  Nat Rev Drug Discov       Date:  2016-07-22       Impact factor: 84.694

Review 3.  In vivo imaging with oligonucleotides for diagnosis and drug development.

Authors:  B Tavitian
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

4.  Eliciting the low-activity aldehyde dehydrogenase Asian phenotype by an antisense mechanism results in an aversion to ethanol.

Authors:  E Garver; Q N Cao; M Aini; F Zhou; Y Israel
Journal:  J Exp Med       Date:  2001-09-03       Impact factor: 14.307

5.  Guidelines for Experiments Using Antisense Oligonucleotides and Double-Stranded RNAs.

Authors:  Keith T Gagnon; David R Corey
Journal:  Nucleic Acid Ther       Date:  2019-03-23       Impact factor: 5.486

Review 6.  Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs.

Authors:  Xiulong Shen; David R Corey
Journal:  Nucleic Acids Res       Date:  2018-02-28       Impact factor: 16.971

Review 7.  AMD Genomics: Non-Coding RNAs as Biomarkers and Therapeutic Targets.

Authors:  Charles Zhang; Leah A Owen; John H Lillvis; Sarah X Zhang; Ivana K Kim; Margaret M DeAngelis
Journal:  J Clin Med       Date:  2022-03-09       Impact factor: 4.241
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.